Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exosome Inhalation for SARS-CoV-2 Pneumonia
NCT04491240Phase 2Completed
- Sponsor
- Samara Regional Medical Center Dinasty
- Start
- Jul 2020
- Primary completion
- Oct 2020
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal stem cell exosomes in COVID-19 pneumonia, sponsored by Samara Regional Medical Center Dinasty. Started Jul 2020; status: completed.
02
Drugs
mesenchymal stem cell exosomes
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04491240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04491240.